Brian K. Kaspar

Affiliations: 
Ohio State University Ohio State University, Columbus, Columbus, OH 
Area:
Spinal Muscular Atrophy, ALS, CNS Gene Delivery, Gene Therapy
Google:
"Brian Kaspar"
Mean distance: 20.46 (cluster 19)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Noroozian Z, Xhima K, Huang Y, et al. (2019) MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain. Methods in Molecular Biology (Clifton, N.J.). 1950: 177-197
Mendell JR, Al-Zaidy S, Shell R, et al. (2017) Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. The New England Journal of Medicine. 377: 1713-1722
Brulet R, Matsuda T, Zhang L, et al. (2017) NEUROD1 Instructs Neuronal Conversion in Non-Reactive Astrocytes. Stem Cell Reports
Webster CP, Smith EF, Bauer CS, et al. (2016) The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. The Embo Journal
Song S, Miranda CJ, Braun L, et al. (2016) Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nature Medicine
Meyer K, Kaspar BK. (2016) Glia - Neuron Interactions in Neurological Diseases: Testing Non-cell Autonomy in a Dish. Brain Research
Sun S, Sun Y, Ling SC, et al. (2015) Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proceedings of the National Academy of Sciences of the United States of America
Israelson A, Ditsworth D, Sun S, et al. (2015) Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron. 86: 218-32
Weber-Adrian D, Thévenot E, O'Reilly MA, et al. (2015) Gene delivery to the spinal cord using MRI-guided focused ultrasound. Gene Therapy. 22: 568-77
Cheever TR, Berkley D, Braun S, et al. (2015) Perspectives on best practices for gene therapy programs. Human Gene Therapy. 26: 127-33
See more...